The P-glycoprotein inhibitor GF120918 modulates Ca2+-dependent processes and lipid metabolism in Toxoplasma gondii.
Up-regulation of the membrane-bound efflux pump P-glycoprotein (P-gp) is associated with the phenomenon of multidrug-resistance in pathogenic organisms, including protozoan parasites. In addition, P-gp plays a role in normal physiological processes, however our understanding of these P-gp functions...
Main Authors: | Iveta Bottova, Ursula Sauder, Vesna Olivieri, Adrian B Hehl, Sabrina Sonda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2851653?pdf=render |
Similar Items
-
Optimization of dose and route of administration of the P‐glycoprotein inhibitor, valspodar (PSC‐833) and the P‐glycoprotein and breast cancer resistance protein dual‐inhibitor, elacridar (GF120918) as dual infusion in rats
by: Christopher Rowbottom, et al.
Published: (2021-04-01) -
The unique glycoproteins of Cryptosporidium parvum and Toxoplasma gondii
by: Haserick, John Robert
Published: (2018) -
Structural basis of surface antigen glycoprotein mediated virulence in Toxoplasma gondii
by: Bruic, Ekaterina
Published: (2009) -
Host lipid droplets: An important source of lipids salvaged by the intracellular parasite Toxoplasma gondii.
by: Sabrina J Nolan, et al.
Published: (2017-06-01) -
Analysis of Structures and Epitopes of Surface Antigen Glycoproteins Expressed in Bradyzoites of Toxoplasma gondii
by: Hua Cong, et al.
Published: (2013-01-01)